Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis (Q38004673)

26 August 2017

0 references

Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis (English)

1 reference

Erratum: Corrigendum: Risk of Clostridium difficile Infection With Acid Suppressing Drugs and Antibiotics: Meta-Analysis

26 August 2017

0 references

Clostridium difficile

0 references

antibiotic

0 references

corrigendum / erratum

1 reference

12 July 2019

http://api.crossref.org/works?select=update-to&filter=doi:10.1038/AJG.2013.413

author

Chun Shing Kwok

1

1 reference

26 August 2017

4

1 reference

26 August 2017

Aaron Kobina Arthur

2

1 reference

26 August 2017

Chukwudubem Ifeanyichukwu Anibueze

3

1 reference

26 August 2017

Rodrigo Cavallazzi

5

1 reference

26 August 2017

Yoon Kong Loke

6

1 reference

26 August 2017

language of work or name

English

0 references

publication date

24 April 2012

1 reference

The American Journal of Gastroenterology

26 August 2017

1 reference

26 August 2017

107

1 reference

26 August 2017

7

1 reference

26 August 2017

1011-1019

1 reference

https://scigraph.springernature.com/pub.10.1038/ajg.2012.108

26 August 2017

0 references

cites work

Proton pump inhibitors and the risk of Clostridium difficile-associated disease: further evidence from the community

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Does PPI therapy predispose to Clostridium difficile infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Fluoroquinolone use and Clostridium difficile-associated diarrhea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Narrative review: the new epidemic of Clostridium difficile-associated enteric disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Successful combat of an outbreak due to Clostridium difficile PCR ribotype 027 and recognition of specific risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Systematic review of the risk of enteric infection in patients taking acid suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Occurrence and significance of gastric colonization during acid-inhibitory therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

When can odds ratios mislead?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Calculating measures of biological interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Albumin, length of stay, and proton pump inhibitors: key factors in Clostridium difficile-associated disease in nursing home patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Clostridium difficile is associated with poor outcomes in patients with cirrhosis: A national and tertiary center perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Case-control study of antibiotic use and subsequent Clostridium difficile-associated diarrhea in hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Association of proton-pump inhibitors with outcomes in Clostridium difficile colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Evaluation of Clostridium difficile-associated disease pressure as a risk factor for C difficile-associated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Clostridium difficile infection in an endemic setting in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Prevalence and clinical course of Clostridium difficile infection in a tertiary-care hospital: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Clostridium difficile in patients undergoing primary hip and knee replacement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

A hospital outbreak of diarrhea due to an emerging epidemic strain of Clostridium difficile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Proton pump inhibitors as a risk factor for recurrence of Clostridium-difficile-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Proton pump inhibitors and risk for recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Clostridium difficile among hospitalized patients receiving antibiotics: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

The relationship between inpatient fluoroquinolone use and Clostridium difficile-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Postoperative Clostridium difficile-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Proton pump inhibitor therapy is a risk factor for Clostridium difficile-associated diarrhoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Quinolone use as a risk factor for nosocomial Clostridium difficile-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Clopidogrel with or without omeprazole in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Reasons or excuses for avoiding meta-analysis in forest plots

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Is over-use of proton pump inhibitors fuelling the current epidemic of Clostridium difficile-associated diarrhoea?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Stress ulcer prophylaxis in the new millennium: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Incidence of and risk factors for community-associated Clostridium difficile infection: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

Host and Pathogen Factors forClostridium difficileInfection and Colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.108

21 January 2018

Identifiers

DOI

10.1038/AJG.2012.108

1 reference

Dimensions Publication ID

26 August 2017

0 references

1 reference